Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing.
Clin Oncol (R Coll Radiol)
; 32(9): 609-617, 2020 09.
Article
em En
| MEDLINE
| ID: mdl-32563549
ABSTRACT
The majority of patients diagnosed with cancer are aged over 65 years and have two or more chronic conditions in addition to cancer and the risk of chronic conditions increases further after cancer. The presence of multimorbidity adds complexity to care, as patients' goals of care and the focus of treatment can change with a diagnosis of cancer. Multimorbidity is frequently associated with polypharmacy, the use of potentially inappropriate medications, the presence of adverse drug reactions and potential drug-drug interactions all of which impact on health outcomes and the cost of care. Consequently, it is vital that a systematic approach is taken to regularly review cancer patients' medication regimens to ensure that they support an optimal balance of benefits with acceptable levels of harm. Several patient and clinician resources are presented to guide the process of medication review and deprescribing.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Polimedicação
/
Tomada de Decisões
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Desprescrições
/
Lista de Medicamentos Potencialmente Inapropriados
/
Multimorbidade
/
Neoplasias
Tipo de estudo:
Prognostic_studies
Limite:
Aged
/
Humans
Idioma:
En
Revista:
Clin Oncol (R Coll Radiol)
Ano de publicação:
2020
Tipo de documento:
Article